Home › Stock analysis › BME
BlackRock Health Sciences (BME) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $44.72, +0.93% vs the prior close of $44.31.
- Volume 45.00K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BME rises 0.9% to $44.72. Closed at $44.72, +0.93% vs the prior close of $44.31. Day range $44.30–$44.99, opened at $44.31.
Last close$44.72+0.93%
Day range44.30–44.99
Open44.31
Volume45.00K
52-week range37.37–46.43
Avg volume (20d)39.30K
BME daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BME rises 0.9% to $44.72
- Closed at $44.72, +0.93% vs the prior close of $44.31. Day range $44.30–$44.99, opened at $44.31.
- Volume was 45.00K shares, 1.1x its 50-day average of 41.16K.
- Price is +0.2% vs its 50-day average ($44.65) and +6.8% vs its 200-day average ($41.86).
- 52-week range $37.37–$46.43; today's close sits at 81% of that range, 3.7% below the 52-week high.
Oct 14, 2026 — BME rises 1.1% to $44.31
- Closed at $44.31, +1.10% vs the prior close of $43.83. Day range $43.74–$44.44, opened at $43.74.
- Volume was 53.20K shares, 1.3x its 50-day average of 41.21K.
- Price is -0.7% vs its 50-day average ($44.62) and +5.9% vs its 200-day average ($41.84).
- 52-week range $37.37–$46.43; today's close sits at 77% of that range, 4.6% below the 52-week high.
Oct 13, 2026 — BME dips 1.2% to $43.83
- Closed at $43.83, -1.17% vs the prior close of $44.35. Day range $43.76–$44.47, opened at $44.47.
- Volume was 49.40K shares, 1.2x its 50-day average of 41.13K.
- Price is -1.7% vs its 50-day average ($44.60) and +4.8% vs its 200-day average ($41.82).
- 52-week range $37.37–$46.43; today's close sits at 71% of that range, 5.6% below the 52-week high.
Oct 12, 2026 — BME rises 0.9% to $44.35
- Closed at $44.35, +0.93% vs the prior close of $43.94. Day range $43.95–$44.44, opened at $44.35.
- Volume was 37.20K shares, 0.9x its 50-day average of 42.08K.
- Price is -0.5% vs its 50-day average ($44.59) and +6.1% vs its 200-day average ($41.81).
- 52-week range $37.37–$46.43; today's close sits at 77% of that range, 4.5% below the 52-week high.
Oct 9, 2026 — BME rises 2.2% to $43.94
- Closed at $43.94, +2.23% vs the prior close of $42.98. Day range $42.87–$43.98, opened at $42.87.
- Volume was 50.20K shares, 1.2x its 50-day average of 42.48K.
- Price is -1.4% vs its 50-day average ($44.57) and +5.1% vs its 200-day average ($41.80).
- 52-week range $37.37–$46.43; today's close sits at 73% of that range, 5.4% below the 52-week high.
Oct 8, 2026 — BME ends flat (-0.2%) to $42.98
- Closed at $42.98, -0.19% vs the prior close of $43.06. Day range $42.39–$43.08, opened at $43.08.
- Volume was 39.90K shares, 0.9x its 50-day average of 42.29K.
- Price is -3.6% vs its 50-day average ($44.57) and +2.9% vs its 200-day average ($41.78).
- 52-week range $37.37–$46.43; today's close sits at 62% of that range, 7.4% below the 52-week high.
Oct 7, 2026 — BME rises 1.2% to $43.06
- Closed at $43.06, +1.15% vs the prior close of $42.57. Day range $42.48–$43.22, opened at $42.48.
- Volume was 40.40K shares, 0.9x its 50-day average of 42.73K.
- Price is -3.4% vs its 50-day average ($44.59) and +3.1% vs its 200-day average ($41.77).
- 52-week range $37.37–$46.43; today's close sits at 63% of that range, 7.3% below the 52-week high.
Oct 6, 2026 — BME dips 0.7% to $42.57, a 1-month low, 8 down days in a row
- Closed at $42.57, -0.65% vs the prior close of $42.85. Day range $42.27–$43.13, opened at $42.90.
- Volume was 56.40K shares, 1.3x its 50-day average of 42.24K.
- Price is -4.6% vs its 50-day average ($44.60) and +1.9% vs its 200-day average ($41.76).
- 52-week range $37.37–$46.43; today's close sits at 57% of that range, 8.3% below the 52-week high.
- That makes 8 straight losses.
Oct 5, 2026 — BME dips 1.1% to $42.85, a 1-month low, 7 down days in a row
- Closed at $42.85, -1.13% vs the prior close of $43.34. Day range $42.56–$43.50, opened at $43.33.
- Volume was 49.50K shares, 1.2x its 50-day average of 42.18K.
- Price is -4.0% vs its 50-day average ($44.61) and +2.6% vs its 200-day average ($41.75).
- 52-week range $37.37–$46.43; today's close sits at 60% of that range, 7.7% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — BME dips 0.6% to $43.34, a 1-month low, 6 down days in a row
- Closed at $43.34, -0.62% vs the prior close of $43.61. Day range $43.23–$43.98, opened at $43.71.
- Volume was 42.50K shares, 1.0x its 50-day average of 42.31K.
- Price is -2.9% vs its 50-day average ($44.61) and +3.8% vs its 200-day average ($41.74).
- 52-week range $37.37–$46.43; today's close sits at 66% of that range, 6.7% below the 52-week high.
- That makes 6 straight losses.
BME latest news & SEC filings
Every SEC filing by or about BME in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 17, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 28, 2026 · N-PX — Annual proxy voting record
Annual proxy voting record
Aug 5, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Things to know before you trade BME
- How much it moves: over the last 20 sessions the average daily move was 0.80% (largest 2.2%). That is a relatively calm stock.
- Liquidity: about 39.30K shares (≈$1.76M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $44.72 vs a range of $37.37–$46.43 (81% of the range).
- Dividends: last ex-dividend date Oct 15, 2026 ($0.262/share); 12 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Jan 21, 2025; 8-K Oct 28, 2016; 8-K Feb 4, 2011.
- Listing: NYSE · industry: —.
BME market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 44.31 | 44.99 | 44.30 | 44.72 | 45.00K |
| Oct 14, 2026 | 43.74 | 44.44 | 43.74 | 44.31 | 53.20K |
| Oct 13, 2026 | 44.47 | 44.47 | 43.76 | 43.83 | 49.40K |
| Oct 12, 2026 | 44.35 | 44.44 | 43.95 | 44.35 | 37.20K |
| Oct 9, 2026 | 42.87 | 43.98 | 42.87 | 43.94 | 50.20K |
| Oct 8, 2026 | 43.08 | 43.08 | 42.39 | 42.98 | 39.90K |
| Oct 7, 2026 | 42.48 | 43.22 | 42.48 | 43.06 | 40.40K |
| Oct 6, 2026 | 42.90 | 43.13 | 42.27 | 42.57 | 56.40K |
| Oct 5, 2026 | 43.33 | 43.50 | 42.56 | 42.85 | 49.50K |
| Oct 2, 2026 | 43.71 | 43.98 | 43.23 | 43.34 | 42.50K |
| Oct 1, 2026 | 44.09 | 44.19 | 43.55 | 43.61 | 32.00K |
| Sep 30, 2026 | 44.80 | 44.80 | 44.13 | 44.13 | 44.10K |
| Sep 29, 2026 | 44.68 | 44.78 | 44.17 | 44.62 | 18.20K |
| Sep 28, 2026 | 44.66 | 44.93 | 44.56 | 44.63 | 43.70K |
| Sep 25, 2026 | 44.95 | 44.95 | 44.71 | 44.84 | 27.70K |
| Sep 24, 2026 | 44.62 | 44.98 | 44.50 | 44.98 | 21.20K |
| Sep 23, 2026 | 45.00 | 45.15 | 44.52 | 44.62 | 39.00K |
| Sep 22, 2026 | 44.47 | 44.99 | 44.24 | 44.99 | 41.40K |
| Sep 21, 2026 | 44.48 | 44.72 | 44.29 | 44.53 | 29.20K |
| Sep 18, 2026 | 44.82 | 44.83 | 44.44 | 44.49 | 25.90K |
About BlackRock Health Sciences
BlackRock Health Sciences (BME) is listed on the NYSE and classified by the SEC under “—”. Its business address is in WILMINGTON, DE. State of incorporation: DE. Fiscal year ends —. SEC CIK 1314966.
BME board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Francis C. Mahoney | Director | Sep 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Charles Park | Chief Compliance Officer | Aug 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BME financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
BME earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BME
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.